46 results on '"Lammert, Frank"'
Search Results
2. Beneficial Effect of Ursodeoxycholic Acid in Patients with ACOX2 Deficiency-Associated Hypertransaminasemia
3. Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
4. Large‐scale computational models of liver metabolism: How far from the clinics?
5. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
6. Vulnerability to alcohol‐associated liver disease: A tale of two systems
7. Long‐Term Colestyramine Treatment Prevents Cholestatic Attacks in Refractory Benign Recurrent Intrahepatic Cholestasis Type 1 Disease
8. Clinical efficacy of highly effective interferon-free therapy in patients with chronic HCV infection and compensated advanced hepatic fibrosis: 76
9. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus
10. Genetic study of FGF19 receptor variants in gallstone disease
11. Common genetic variation in vitamin D metabolism is associated with liver stiffness
12. Influence of dietary intake, body mass index, body fat mass, age and gender on basal FGF-19 serum concentrations in overweight and obese NAFLD patients: 1488
13. Failure to Down-regulate Bile Acid Synthesis in Overweight and Obese NAFLD Patients with Impaired Intestinal FGF19 Release: 1478
14. Identification of cis-regulated genes in quantitative trait loci affecting liver fibrosis: 1226
15. Dissecting fibrogenesis: QTL mapping of murine hepatocellular damage to a 6 Mb locus on chromosome 11 in vitro and in vivo: 1197
16. The common variant rs3790844 in the nuclear receptor NR5A2 increases risk of cholangiocarcinoma: 512
17. Gallstone Disease in Swedish Twins is Linked to the Gilbert Variant of UGT1A1: 286
18. Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease
19. Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark?
20. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians
21. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
22. The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin-13 as driving forces in fibrogenesis#
23. The transporter “variome”: The missing link between gene variants and bile salt transporter function#†
24. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine
25. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol
26. Investigation of the Lith1 candidate genes ABCB11 and LXRA in human gallstone disease
27. Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood
28. Severe drug‐induced liver injury related to therapy with dimethyl fumarate
29. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at theABCG5/8lithogenic locus
30. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians
31. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis
32. A yellow bullet against the drivers of hepatic fibrogenesis
33. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats
34. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine
35. Investigation of theLith1 candidate genesABCB11 andLXRA in human gallstone disease
36. Coinheritance of Gilbert syndrome–associatedUGT1A1 mutation increases gallstone risk in cystic fibrosis
37. Intrahepatic cholestasis of pregnancy: A randomized controlled trial comparing dexamethasone and ursodeoxycholic acid
38. Genetic and environmental influences on symptomatic gallstone disease: A Swedish study of 43,141 twin pairs
39. Haplotype-taggingRANTES gene variants influence response to antiviral therapy in chronic hepatitis C
40. From genotypes to haplotypes in hepatobiliary diseases: One plus one equals (sometimes) more than two
41. Spontaneous cholecysto- and hepatolithiasis inMdr2?/? mice: A model for low phospholipid-associated cholelithiasis
42. Lithgenes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice
43. Nuclear xeno-sensors as receptors for cholestatic bile acids: The second line of defense
44. 474 Risk factors for cholesterol gallstone formation are associated with common polymorphisms of ABCG5/ABCG8, the genes encoding the biliary cholesterol half-transporters in German and Mexican gallstone patients
45. 468 Cholestasis leads to downregulation of intestinal MRP2 in rats and humans and increases oral bioavailability of a food-derived carcinogen
46. 465 Cytokine-dependent regulation of nuclear hormone receptors and corresponding hepatic transporter genes in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.